Click for best price
Pets Antiinfective Drugs Market Size, Share 2023
Rising pet adoption coupled with rising concerns regarding pet health and prevalence of bacterial infection, especially in dogs, is anticipated to further propel the market growth. Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. According to the qualitative report by the CDC in 2018, cats are more prone to plague than dogs and can pass on the infection to humans as well.
This report aims to provide a comprehensive presentation of the global market for Pets Anti-infective Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets Anti-infective Drugs. This report contains market size and forecasts of Pets Anti-infective Drugs in global, including the following market information:
Global Pets Anti-infective Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Pets Anti-infective Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pets Anti-infective Drugs include Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol and Bimeda Animal Health, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Pets Anti-infective Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pets Anti-infective Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Pets Anti-infective Drugs Market Segment Percentages, by Type, 2022 (%)
Injection
Oral
Others
Global Pets Anti-infective Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Pets Anti-infective Drugs Market Segment Percentages, by Application, 2022 (%)
Dog
Cat
Others
Global Pets Anti-infective Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Pets Anti-infective Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pets Anti-infective Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pets Anti-infective Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Chanelle
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pets Anti-infective Drugs, market overview.
Chapter 2: Global Pets Anti-infective Drugs market size in revenue.
Chapter 3: Detailed analysis of Pets Anti-infective Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pets Anti-infective Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Pets Anti-infective Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pets Anti-infective Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pets Anti-infective Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pets Anti-infective Drugs Overall Market Size
2.1 Global Pets Anti-infective Drugs Market Size: 2022 VS 2030
2.2 Global Pets Anti-infective Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pets Anti-infective Drugs Players in Global Market
3.2 Top Global Pets Anti-infective Drugs Companies Ranked by Revenue
3.3 Global Pets Anti-infective Drugs Revenue by Companies
3.4 Top 3 and Top 5 Pets Anti-infective Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pets Anti-infective Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pets Anti-infective Drugs Players in Global Market
3.6.1 List of Global Tier 1 Pets Anti-infective Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Pets Anti-infective Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pets Anti-infective Drugs Market Size Markets, 2022 & 2030
4.1.2 Injection
4.1.3 Oral
4.1.4 Others
4.2 By Type - Global Pets Anti-infective Drugs Revenue & Forecasts
4.2.1 By Type - Global Pets Anti-infective Drugs Revenue, 2018-2023
4.2.2 By Type - Global Pets Anti-infective Drugs Revenue, 2024-2030
4.2.3 By Type - Global Pets Anti-infective Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pets Anti-infective Drugs Market Size, 2022 & 2030
5.1.2 Dog
5.1.3 Cat
5.1.4 Others
5.2 By Application - Global Pets Anti-infective Drugs Revenue & Forecasts
5.2.1 By Application - Global Pets Anti-infective Drugs Revenue, 2018-2023
5.2.2 By Application - Global Pets Anti-infective Drugs Revenue, 2024-2030
5.2.3 By Application - Global Pets Anti-infective Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Pets Anti-infective Drugs Market Size, 2022 & 2030
6.2 By Region - Global Pets Anti-infective Drugs Revenue & Forecasts
6.2.1 By Region - Global Pets Anti-infective Drugs Revenue, 2018-2023
6.2.2 By Region - Global Pets Anti-infective Drugs Revenue, 2024-2030
6.2.3 By Region - Global Pets Anti-infective Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Pets Anti-infective Drugs Revenue, 2018-2030
6.3.2 US Pets Anti-infective Drugs Market Size, 2018-2030
6.3.3 Canada Pets Anti-infective Drugs Market Size, 2018-2030
6.3.4 Mexico Pets Anti-infective Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Pets Anti-infective Drugs Revenue, 2018-2030
6.4.2 Germany Pets Anti-infective Drugs Market Size, 2018-2030
6.4.3 France Pets Anti-infective Drugs Market Size, 2018-2030
6.4.4 U.K. Pets Anti-infective Drugs Market Size, 2018-2030
6.4.5 Italy Pets Anti-infective Drugs Market Size, 2018-2030
6.4.6 Russia Pets Anti-infective Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Pets Anti-infective Drugs Market Size, 2018-2030
6.4.8 Benelux Pets Anti-infective Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Pets Anti-infective Drugs Revenue, 2018-2030
6.5.2 China Pets Anti-infective Drugs Market Size, 2018-2030
6.5.3 Japan Pets Anti-infective Drugs Market Size, 2018-2030
6.5.4 South Korea Pets Anti-infective Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Pets Anti-infective Drugs Market Size, 2018-2030
6.5.6 India Pets Anti-infective Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Pets Anti-infective Drugs Revenue, 2018-2030
6.6.2 Brazil Pets Anti-infective Drugs Market Size, 2018-2030
6.6.3 Argentina Pets Anti-infective Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pets Anti-infective Drugs Revenue, 2018-2030
6.7.2 Turkey Pets Anti-infective Drugs Market Size, 2018-2030
6.7.3 Israel Pets Anti-infective Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Pets Anti-infective Drugs Market Size, 2018-2030
6.7.5 UAE Pets Anti-infective Drugs Market Size, 2018-2030
7 Pets Anti-infective Drugs Companies Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Company Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Pets Anti-infective Drugs Major Product Offerings
7.1.4 Boehringer Ingelheim Pets Anti-infective Drugs Revenue in Global Market (2018-2023)
7.1.5 Boehringer Ingelheim Key News & Latest Developments
7.2 Zoetis
7.2.1 Zoetis Company Summary
7.2.2 Zoetis Business Overview
7.2.3 Zoetis Pets Anti-infective Drugs Major Product Offerings
7.2.4 Zoetis Pets Anti-infective Drugs Revenue in Global Market (2018-2023)
7.2.5 Zoetis Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Pets Anti-infective Drugs Major Product Offerings
7.3.4 Merck Pets Anti-infective Drugs Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Elanco
7.4.1 Elanco Company Summary
7.4.2 Elanco Business Overview
7.4.3 Elanco Pets Anti-infective Drugs Major Product Offerings
7.4.4 Elanco Pets Anti-infective Drugs Revenue in Global Market (2018-2023)
7.4.5 Elanco Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Pets Anti-infective Drugs Major Product Offerings
7.5.4 Bayer Pets Anti-infective Drugs Revenue in Global Market (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Virbac
7.6.1 Virbac Company Summary
7.6.2 Virbac Business Overview
7.6.3 Virbac Pets Anti-infective Drugs Major Product Offerings
7.6.4 Virbac Pets Anti-infective Drugs Revenue in Global Market (2018-2023)
7.6.5 Virbac Key News & Latest Developments
7.7 Ceva Sante Animale
7.7.1 Ceva Sante Animale Company Summary
7.7.2 Ceva Sante Animale Business Overview
7.7.3 Ceva Sante Animale Pets Anti-infective Drugs Major Product Offerings
7.7.4 Ceva Sante Animale Pets Anti-infective Drugs Revenue in Global Market (2018-2023)
7.7.5 Ceva Sante Animale Key News & Latest Developments
7.8 Vetoquinol
7.8.1 Vetoquinol Company Summary
7.8.2 Vetoquinol Business Overview
7.8.3 Vetoquinol Pets Anti-infective Drugs Major Product Offerings
7.8.4 Vetoquinol Pets Anti-infective Drugs Revenue in Global Market (2018-2023)
7.8.5 Vetoquinol Key News & Latest Developments
7.9 Bimeda Animal Health
7.9.1 Bimeda Animal Health Company Summary
7.9.2 Bimeda Animal Health Business Overview
7.9.3 Bimeda Animal Health Pets Anti-infective Drugs Major Product Offerings
7.9.4 Bimeda Animal Health Pets Anti-infective Drugs Revenue in Global Market (2018-2023)
7.9.5 Bimeda Animal Health Key News & Latest Developments
7.10 Chanelle
7.10.1 Chanelle Company Summary
7.10.2 Chanelle Business Overview
7.10.3 Chanelle Pets Anti-infective Drugs Major Product Offerings
7.10.4 Chanelle Pets Anti-infective Drugs Revenue in Global Market (2018-2023)
7.10.5 Chanelle Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pets Anti-infective Drugs Market Opportunities & Trends in Global Market
Table 2. Pets Anti-infective Drugs Market Drivers in Global Market
Table 3. Pets Anti-infective Drugs Market Restraints in Global Market
Table 4. Key Players of Pets Anti-infective Drugs in Global Market
Table 5. Top Pets Anti-infective Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pets Anti-infective Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pets Anti-infective Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pets Anti-infective Drugs Product Type
Table 9. List of Global Tier 1 Pets Anti-infective Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pets Anti-infective Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pets Anti-infective Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Pets Anti-infective Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pets Anti-infective Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Pets Anti-infective Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Pets Anti-infective Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pets Anti-infective Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Pets Anti-infective Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Pets Anti-infective Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pets Anti-infective Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pets Anti-infective Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pets Anti-infective Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pets Anti-infective Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pets Anti-infective Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pets Anti-infective Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Boehringer Ingelheim Company Summary
Table 31. Boehringer Ingelheim Pets Anti-infective Drugs Product Offerings
Table 32. Boehringer Ingelheim Pets Anti-infective Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Boehringer Ingelheim Key News & Latest Developments
Table 34. Zoetis Company Summary
Table 35. Zoetis Pets Anti-infective Drugs Product Offerings
Table 36. Zoetis Pets Anti-infective Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Zoetis Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Pets Anti-infective Drugs Product Offerings
Table 40. Merck Pets Anti-infective Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Elanco Company Summary
Table 43. Elanco Pets Anti-infective Drugs Product Offerings
Table 44. Elanco Pets Anti-infective Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Elanco Key News & Latest Developments
Table 46. Bayer Company Summary
Table 47. Bayer Pets Anti-infective Drugs Product Offerings
Table 48. Bayer Pets Anti-infective Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. Virbac Company Summary
Table 51. Virbac Pets Anti-infective Drugs Product Offerings
Table 52. Virbac Pets Anti-infective Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Virbac Key News & Latest Developments
Table 54. Ceva Sante Animale Company Summary
Table 55. Ceva Sante Animale Pets Anti-infective Drugs Product Offerings
Table 56. Ceva Sante Animale Pets Anti-infective Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Ceva Sante Animale Key News & Latest Developments
Table 58. Vetoquinol Company Summary
Table 59. Vetoquinol Pets Anti-infective Drugs Product Offerings
Table 60. Vetoquinol Pets Anti-infective Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Vetoquinol Key News & Latest Developments
Table 62. Bimeda Animal Health Company Summary
Table 63. Bimeda Animal Health Pets Anti-infective Drugs Product Offerings
Table 64. Bimeda Animal Health Pets Anti-infective Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Bimeda Animal Health Key News & Latest Developments
Table 66. Chanelle Company Summary
Table 67. Chanelle Pets Anti-infective Drugs Product Offerings
Table 68. Chanelle Pets Anti-infective Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Chanelle Key News & Latest Developments
List of Figures
Figure 1. Pets Anti-infective Drugs Segment by Type in 2022
Figure 2. Pets Anti-infective Drugs Segment by Application in 2022
Figure 3. Global Pets Anti-infective Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pets Anti-infective Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Pets Anti-infective Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pets Anti-infective Drugs Revenue in 2022
Figure 8. By Type - Global Pets Anti-infective Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Pets Anti-infective Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Pets Anti-infective Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Pets Anti-infective Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Pets Anti-infective Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Pets Anti-infective Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Pets Anti-infective Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Pets Anti-infective Drugs Revenue Market Share, 2018-2030
Figure 16. US Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Pets Anti-infective Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Pets Anti-infective Drugs Revenue Market Share, 2018-2030
Figure 28. China Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Pets Anti-infective Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Pets Anti-infective Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Pets Anti-infective Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Boehringer Ingelheim Pets Anti-infective Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Zoetis Pets Anti-infective Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Pets Anti-infective Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Elanco Pets Anti-infective Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer Pets Anti-infective Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Virbac Pets Anti-infective Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Ceva Sante Animale Pets Anti-infective Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Vetoquinol Pets Anti-infective Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bimeda Animal Health Pets Anti-infective Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Chanelle Pets Anti-infective Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
